D-0653-2026 Class II Ongoing

Recalled by ACCORD BIOPHARMA INC — Raleigh, NC

FDA drug recall D-0653-2026 was initiated by ACCORD BIOPHARMA INC on Jun 10, 2026 and is designated Class II. Reason for recall: Lack of assurance of Sterility: The recall status is ongoing. Affected quantity: 326 vials.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Jun 10, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
326 vials

Product description

IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Indiana, LLC, 1300 S. Patterson Drive, Bloomington, IN 47403, USA, NDC 69448-019-26.

Reason for recall

Lack of assurance of Sterility:

Distribution pattern

US Nationwide.

Code information

Lot # 004L24A, Exp Date: 02/19/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0653-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0653-2026. Report a data issue: hello@regdatalab.com.